Latest News

25 November, 2022

NHMRC grant brings synergy to strategies for malaria elimination

A Burnet-led team has been awarded a $5 million NHMRC Synergy grant to develop multiple strategies to interrupt malaria transmission.

24 November, 2022

Focus on prevention in Burnet Long COVID submission

The importance of prevention is a key theme of Burnet Institute’s submission to the House of Representatives Health Committee Inquiry into Long COVID.

22 November, 2022

Professor Brendan Crabb admitted to the Australian Academy of Science

Burnet Institute Director and CEO Professor Brendan Crabb has been formally admitted as a Fellow of the Australian Academy of Science at an event at the iconic Shine Dome today.

22 November, 2022

New insights into medicines for pre-eclampsia

Burnet Institute researchers have led the development of the first global strategic guidelines for medicines for pre-eclampsia, one of the leading causes of maternal deaths globally.

18 November, 2022

Australia falling behind in goal to eliminate hepatitis C, new report shows

New models of care and investment are urgently needed to reach people at risk or living with hepatitis C, otherwise Australia risks falling short of its goal to eliminate hepatitis C by 2030.

07 November, 2022

Reducing the impacts of chlamydia in Australia

We need to do more to prevent and manage chlamydia in Australia, argues a new MJA Perspective article led by Burnet Institute.

More News

Subscribe: RSS, Email

Upcoming Events

01 December, 2022

World AIDS Day Victorian Community Launch and mHIVE Symposium

Burnet Institute is proud to support the 2022 World AIDS Day Victorian Community Launch and mHIVE Symposium focused on the issues facing women living with HIV.

More Events

Subscribe: RSS, Email